IL11 administration resulted in a significant increase in tumour volume by 7 days of treatment, at which point the tumours approached our ethical maximum volume limit (977.25 mm3 ± 5.52 versus saline control 567.93 mm3 ± 10.11; p < 0.01) (Figure 3C). The gene discussed is IL11; the disease is neoplasm.